Literature DB >> 17590459

Monte Carlo approaches for determining power and sample size in low-prevalence applications.

Michael S Williams1, Eric D Ebel, Bruce A Wagner.   

Abstract

The prevalence of disease in many populations is often low. For example, the prevalence of tuberculosis, brucellosis, and bovine spongiform encephalopathy range from 1 per 100,000 to less than 1 per 1,000,000 in many countries. When an outbreak occurs, epidemiological investigations often require comparing the prevalence in an exposed population with that of an unexposed population. To determine if the level of disease in the two populations is significantly different, the epidemiologist must consider the test to be used, desired power of the test, and determine the appropriate sample size for both the exposed and unexposed populations. Commonly available software packages provide estimates of the required sample sizes for this application. This study shows that these estimated sample sizes can exceed the necessary number of samples by more than 35% when the prevalence is low. We provide a Monte Carlo-based solution and show that in low-prevalence applications this approach can lead to reductions in the total samples size of more than 10,000 samples.

Entities:  

Mesh:

Year:  2007        PMID: 17590459     DOI: 10.1016/j.prevetmed.2007.05.015

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  3 in total

1.  How many therapists? Practical guidance on investigating therapist effects in randomized controlled trials for eating disorders.

Authors:  Doug Thompson; Fary Cachelin; Ruth H Striegel-Moore; Bruce Barton; Munyi Shea; G Terence Wilson
Journal:  Int J Eat Disord       Date:  2012-03-12       Impact factor: 4.861

2.  Efficient and flexible simulation-based sample size determination for clinical trials with multiple design parameters.

Authors:  Duncan T Wilson; Richard Hooper; Julia Brown; Amanda J Farrin; Rebecca Ea Walwyn
Journal:  Stat Methods Med Res       Date:  2020-12-02       Impact factor: 3.021

3.  Comparative assessment of passive surveillance in disease-free and endemic situation: example of Brucella melitensis surveillance in Switzerland and in Bosnia and Herzegovina.

Authors:  Daniela C Hadorn; Sabina Seric Haracic; Katharina D C Stärk
Journal:  BMC Vet Res       Date:  2008-12-22       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.